Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Inventory (2016 - 2025)

Historic Inventory for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $7.8 million.

  • National Healthcare's Inventory rose 5.1% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 5.1%. This contributed to the annual value of $9.0 million for FY2024, which is 2238.02% up from last year.
  • As of Q3 2025, National Healthcare's Inventory stood at $7.8 million, which was up 5.1% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Inventory ranged from a high of $9.0 million in Q4 2024 and a low of $6.6 million during Q2 2024
  • Its 5-year average for Inventory is $7.7 million, with a median of $7.8 million in 2024.
  • In the last 5 years, National Healthcare's Inventory plummeted by 1910.09% in 2023 and then skyrocketed by 2238.02% in 2024.
  • Quarter analysis of 5 years shows National Healthcare's Inventory stood at $8.6 million in 2021, then dropped by 17.41% to $7.1 million in 2022, then rose by 4.2% to $7.4 million in 2023, then increased by 22.38% to $9.0 million in 2024, then decreased by 13.22% to $7.8 million in 2025.
  • Its last three reported values are $7.8 million in Q3 2025, $7.9 million for Q2 2025, and $8.1 million during Q1 2025.